Leerink Partnrs Issues Negative Forecast for EHC Earnings

Encompass Health Co. (NYSE:EHC - Free Report) - Equities research analysts at Leerink Partnrs cut their Q2 2025 earnings per share (EPS) estimates for Encompass Health in a research report issued to clients and investors on Tuesday, February 11th. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn $1.18 per share for the quarter, down from their prior estimate of $1.23. The consensus estimate for Encompass Health's current full-year earnings is $4.76 per share. Leerink Partnrs also issued estimates for Encompass Health's Q2 2026 earnings at $1.20 EPS, FY2027 earnings at $5.23 EPS and FY2028 earnings at $5.43 EPS.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%.

EHC has been the subject of a number of other research reports. Truist Financial reaffirmed a "buy" rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp raised their price target on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $110.00 price target on shares of Encompass Health in a research note on Tuesday, February 11th. Finally, Barclays raised their price objective on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, February 7th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $107.67.

Encompass Health Trading Up 0.8 %

Shares of NYSE:EHC traded up $0.77 during trading on Thursday, reaching $100.91. 588,630 shares of the company traded hands, compared to its average volume of 601,568. The firm has a market capitalization of $10.17 billion, a price-to-earnings ratio of 22.62, a P/E/G ratio of 1.18 and a beta of 0.90. Encompass Health has a 52-week low of $73.02 and a 52-week high of $104.55. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The business's fifty day moving average is $95.97 and its 200-day moving average is $95.56.

Insider Activity

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 2.10% of the company's stock.

Institutional Investors Weigh In On Encompass Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. MassMutual Private Wealth & Trust FSB increased its position in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares during the last quarter. Colonial Trust Co SC bought a new position in shares of Encompass Health during the 4th quarter valued at approximately $29,000. UMB Bank n.a. grew its stake in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company's stock valued at $31,000 after acquiring an additional 252 shares during the period. V Square Quantitative Management LLC grew its stake in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock valued at $39,000 after acquiring an additional 140 shares during the period. Finally, Avior Wealth Management LLC bought a new position in shares of Encompass Health during the 3rd quarter valued at approximately $40,000. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.